Your session is about to expire
← Back to Search
Local Anesthetic
1 for Overactive Bladder
Phase 3
Waitlist Available
Led By Frank F. Tu, MD, MPH
Research Sponsored by Frank Tu
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Summary
The purpose of this study is to determine whether alkalized lidocaine instilled into the bladder is effective in the treatment of overactive bladder (OAB).
Eligible Conditions
- Overactive Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Average Weekly NRS for Frequency at 6 Weeks
Cystometric Assessment of Maximal Bladder Capacity at 6 Weeks Only.
Global Assessment of Change - Frequency at 6 Weeks
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
xylocaine
Group II: 2Placebo Group1 Intervention
normal saline
Find a Location
Who is running the clinical trial?
Berlex FoundationOTHER
1 Previous Clinical Trials
25 Total Patients Enrolled
Frank TuLead Sponsor
Frank F. Tu, MD, MPHPrincipal InvestigatorNorthShore University HealthSystem
Share this study with friends
Copy Link
Messenger